Inactive Instrument

Analyst Reco. StemCells Inc Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 29	Microbot Medical Announces Positive Results from the First Phase of Its Collaboration with Corewell Health	CI
Apr. 16	HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating	MT

HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating	Apr. 16	MT
HC Wainwright Adjusts Price Target on Microbot Medical to $8 From $20, Keeps Buy Rating	23-05-09	MT

No results for this search